We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

133 hedge funds and large institutions have $892M invested in Genomic Health, Inc. in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 38 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 38

3% more capital invested

Capital invested by funds: $870M → $892M (+$22.1M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

1% less funds holding

Funds holding: 134 → 133 (-1)

Holders
133
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
3.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
53
Reduced
38
Closed
16
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$220K

Top Buyers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
+$24.6M
2
BFA
BlackRock Fund Advisors
California
+$3.35M
3
Morgan Stanley
Morgan Stanley
New York
+$3.19M
4
American Century Companies
American Century Companies
Missouri
+$2.94M
5
Millennium Management
Millennium Management
New York
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$15.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.65M
3
NI
Numeric Investors
Massachusetts
-$2.96M
4
LCM
Laurion Capital Management
New York
-$2.72M
5
CC
Casdin Capital
New York
-$2.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
26
BlackRock Group
United Kingdom
$4.16M -$84.3K -2,766 -2%
AllianceBernstein
27
AllianceBernstein
Tennessee
$4.07M +$1.49M +48,920 +55%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$4M -$615K -20,186 -13%
Mitsubishi UFJ Trust & Banking
29
Mitsubishi UFJ Trust & Banking
Japan
$3.92M -$584K -19,160 -13%
MFAM
30
Motley Fool Asset Management
Virginia
$3.88M – – –
American Century Companies
31
American Century Companies
Missouri
$3.74M +$2.94M +96,472 +314%
MFWM
32
Motley Fool Wealth Management
Virginia
$3.62M +$116K +3,812 +3%
Skandinaviska Enskilda Banken (SEB)
33
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.61M -$189K -6,200 -5%
OC
34
Oppenheimer & Co
New York
$3.2M -$915K -30,000 -22%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$3.08M +$1.25M +40,900 +64%
BIM
36
Bogle Investment Management
Massachusetts
$3.03M +$992K +32,554 +46%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.59M +$62.2K +2,039 +2%
BIM
38
BlackRock Investment Management
Delaware
$2.58M +$12.3K +403 +0.5%
CS
39
Candriam SCA
Luxembourg
$2.56M +$244K +8,000 +10%
CCMH
40
Cornerstone Capital Management Holdings
New York
$2.32M -$1.84M -60,457 -43%
SI
41
Scout Investments
Missouri
$2.06M – – –
PAM
42
Panagora Asset Management
Massachusetts
$2.06M -$91.4K -2,998 -4%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$2.02M +$1.81M +59,247 +821%
Wells Fargo
44
Wells Fargo
California
$1.98M +$217K +7,116 +12%
TCIM
45
TIAA CREF Investment Management
New York
$1.98M -$60.1K -1,971 -3%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$1.95M -$45.7K -1,500 -2%
EU
47
Emory University
Georgia
$1.89M +$1.96M +64,147 New
CS
48
Credit Suisse
Switzerland
$1.71M +$285K +9,345 +19%
SCA
49
Secor Capital Advisors
New York
$1.66M -$303K -9,933 -15%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$1.65M -$779K -25,538 -31%
1
2
3 4 5

GHDX Hedge Fund Activity: Q4 2016 in Review

133 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2016, worth a combined $892M — up 2.5% from $870M a quarter earlier.

Fund positioning in GHDX was balanced in Q4 2016: 16 funds opened new positions, 16 closed out, 53 added to existing stakes and 38 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $24.6M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $15.9M sold.

  • 133 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2016, down from 134 in Q3 2016.
  • Funds reported $892M of Genomic Health, Inc. stock for Q4 2016, up 2.5% quarter-over-quarter.
  • 16 funds opened new Genomic Health, Inc. positions in Q4 2016 and 16 closed out, a net change of 0 holders.
  • The largest Genomic Health, Inc. buyer in Q4 2016 was Columbia Wanger Asset Management, an estimated $24.6M added.
  • The largest Genomic Health, Inc. seller in Q4 2016 was Baillie Gifford & Co, an estimated $15.9M sold.

Based on aggregated 13F filings for Q4 2016.